5% Dextrose Injection — Class I drug recall D-1162-2014
Terminated recall by Baxter Healthcare Corp., reported 2014-03-26, distributed nationwide. Presence of Paticulate Matter; Baxter is issuing a voluntary recall for these IV solutions due to particulate
| Recall number | D-1162-2014 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Baxter Healthcare Corp., Deerfield, IL, United States |
| Recall initiated | 2013-11-21 |
| Classified | 2014-03-14 |
| Reported by FDA | 2014-03-26 |
| Terminated | 2016-09-21 |
| Distributed | Nationwide (US) |
| Countries outside the US | AE, SA, SG |
| Quantity | 105,216 containers |
| Reason classes | specification failure |
| NDC | 00338-0017, 00338-0017-02, 00338-0017-03, 00338-0017-04, 00338-0017-10, 00338-0017-11, 00338-0017-18, 00338-0017-31, 00338-0017-38, 00338-0017-41, 00338-0017-48, 00338-0023, 00338-0023-02, 00338-0023-03, 00338-0023-04 |
| Lot numbers | 11/13, P285288 |
Product
5% Dextrose Injection, USP, 100 mL Single dose VIAFLEX plastic containers, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, Product code 2B0089, NDC 0338-0017-38.
Reason for recall
Presence of Paticulate Matter; Baxter is issuing a voluntary recall for these IV solutions due to particulate matter found in the solution identified as polyester and cotton fibers, adhesive-like mixture, polyacetal particles, thermally degraded PVC, black polypropylene and human hair embedded in the plastic bag
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1162-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.